{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:21:01Z","timestamp":1787840461415,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To study the clinical profile of hepatocellular carcinoma (HCC) in a tertiary care hospital and alpha fetoprotein correlation (AFP) with radiological tumor size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A prospective observational study was conducted from February 2023 to August 2024. There were 57 cases of HCC enrolled. Patient details were noted, such as demographics, clinical characteristics, tumor characteristics, disease severity and their treatment. The data was compiled and analyzed. The outcome measures were association of tumor size with AFP levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Patients had a mean age of 63.1 years and a BMI of 27.02 kg\/m\u00b2. Common risk factors were diabetes mellitus and alcohol in 47.4% and 43.9%, respectively. The common symptoms were abdominal pain (right hypochondrium) in 40 (70.2%) patients, abdominal distension in 36 (63.2%), jaundice in 19 (33.3%), weight loss in 10 (17.5%), fever in 8 (14.0%). Hepatomegaly was present in 29 (50.9%) patients, ascites in 27 (47.4%), splenomegaly in 10 (17.5%), liver bruit and pleural effusion in 6 (10.5%) patients each, and hepatic encephalopathy in 4 (7.0%) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>HCC patients were primarily older men with diabetes and alcohol being common risk factors. Abdominal pain and distention remain common findings with complications of cirrhosis, esophageal varices, and pleural effusion. AFP levels and imaging modalities were the most important aids for the diagnosis, management and prognosis. Majority of the treatment remains supportive in the form of transarterial chemoembolization (TACE), transarterial radioembolization (TARE), stereotactic body radiation therapy (SBRT) etc. with few cases demanding interventional therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jpbs.jpbs_1864_24","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:03:13Z","timestamp":1750208593000},"page":"S1940-S1945","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Hepatocellular Carcinoma in South Indian Population: Clinical Profile and AFP Correlation with Radiological Tumor Size"],"prefix":"10.4103","volume":"17","author":[{"given":"Sahil","family":"Ahmad","sequence":"first","affiliation":[{"name":"Department of Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Seshadri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.3390\/cancers15215215","article-title":"Changes in the Epidemiology of hepatocellular carcinoma in Carinthia, Austria, 2012-2023","volume":"15","author":"Hucke","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3350\/cmh.2021.0395","article-title":"Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly","volume":"29","author":"Chon","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: Trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"4","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jceh.2019.01.004","article-title":"Hepatocellular carcinoma: Etiology and current and future drugs","volume":"2","author":"Jindal","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"R8-20250618","first-page":"863","article-title":"Hepatocellular carcinoma: A comprehensive review of biomarkers, clinical aspects, and therapy","volume":"18","author":"Tunissiolli","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular carcinoma: A review","volume":"3","author":"Balogh","year":"2016","journal-title":"J Hepatocell Carcinoma"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1572-0241.2007.01370.x","article-title":"The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: A prospective sequential survey","volume":"102","author":"Huo","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jso.1101","article-title":"AJCC\/TNM cancer staging, present and future","volume":"77","author":"Fleming","year":"2001","journal-title":"J Surg Oncol"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"200","DOI":"10.14740\/jocmr4902","article-title":"Prognostic scores and survival rates by etiology of hepatocellular carcinoma: A review","volume":"15","author":"Calderon-Martinez","year":"2023","journal-title":"J Clin Med Res"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1158\/1078-0432.CCR-04-1715","article-title":"p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma","volume":"10","author":"Li","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"e19812","DOI":"10.2196\/19812","article-title":"Predicting hepatocellular carcinoma with minimal features from electronic health records: Development of a deep learning model","volume":"7","author":"Liang","year":"2021","journal-title":"JMIR Cancer"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12664-021-01209-0","article-title":"Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India","volume":"41","author":"Musunuri","year":"2022","journal-title":"Indian J Gastroenterol"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jceh.2022.05.006","article-title":"Clinical profile, patterns of care and adherence to guidelines in patients with hepatocellular carcinoma: Prospective multi-center study","volume":"12","author":"Shukla","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4103\/crst.crst_37_23","article-title":"Etiology, clinical profile, and treatment pattern of hepatocellular carcinoma at a tertiary care center in North India: A retrospective observational study","volume":"6","author":"Parveen","year":"2023","journal-title":"Cancer Res Stat Treat"},{"key":"R21-20250618","first-page":"31","article-title":"Study on the clinical and etiological profile of hepatocellular carcinoma in a tertiary care centre in south India: A prospective observational study","volume":"10","author":"Revathy","year":"2023","journal-title":"Int J Adv Med"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/jcm8101736","article-title":"Normal alpha-fetoprotein hepatocellular carcinoma: Are they really normal?","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"032056","DOI":"10.1088\/1742-6596\/1073\/3\/032056","article-title":"Correlation between serum level of alpha-fetoprotein and histological differentiation grade of hepatocellular carcinoma","volume":"1073","author":"Lalisang","year":"2018","journal-title":"J Phys Conf Ser"},{"key":"R24-20250618","first-page":"123","article-title":"Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma","volume":"51","author":"Sharieff","year":"2001","journal-title":"J Pak Med Assoc"},{"key":"R25-20250618","first-page":"453","article-title":"HCC with low- and normal-serum alpha-fetoprotein levels","volume":"15","author":"Carr","year":"2018","journal-title":"Clin Pract (Lond)"},{"key":"R26-20250618","first-page":"e24506","article-title":"Correlation between serum alpha-fetoprotein and tumour size in patients with hepatocellular carcinoma treated with direct-acting antivirals","volume":"14","author":"Rusie","year":"2022","journal-title":"Cureus"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_1864_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:23:15Z","timestamp":1787836995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_1864_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":24,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_1864_24","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2024-12-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}